Dexcom down 7% after hours despite quarterly beats, 2024 outlook updates


Rolled newspaper with the headline Quarterly Results

Zerbor/iStock via Getty Images

  • Despite releasing Q1 2024 results that beat on both lines, Dexcom (NASDAQ:DXCM) is down ~7% in after-hours trading Thursday.
  • The continuous glucose monitor maker’s updated 2024 revenue outlook range is now $4.20B-$4.35B. Consensus is $4.33B.
  • The company did not provide EPS guidance. However, the

Source link

Leave A Reply

Your email address will not be published.